RxDoctor Payments Data

Keerat Singh, MD

Adult Reconstructive Orthopaedic Surgery · Phoenix, AZNPI 1083971691

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 55.9% of the total. Reporting peaked in 2021 at $4,893 and has fallen 94.3% since, to $280 in 2024.

$11,257in general payments, 2019–2025

Across 87 payments — averaging $129.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$6K
  • Medacta USA, Inc.$1K
  • Zimmer Biomet$1K
  • United Orthopedics LLC$1K
  • Stryker$698
  • Johnson & Johnson$538
  • plus $173 from 2 others
$42,089in research payments, 2019–2025

Across 8 payments — averaging $5261.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$42K

What the payments were for

  • Consulting fees$2,54423%
  • Travel & lodging$3,98735%
  • Food & beverage$3,51331%
  • Education$1,21311%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,257 in reported general payments places this provider in the 60th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.

See all adult reconstructive orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$29,122
Medicare patients
80
Services billed
595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen29$253
Meloxicam12$35

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →